Closing Bell: Sensex Down 28 Points, Nifty Down at 22,932 on February 19, 2025

The BSE Sensex closed at 75,939.18, registering a modest decline of 28.21 points, or -0.04%. Similarly, the Nifty 50 ended at 22,932.90, down by 12.40 points, or -0.05%

Indian benchmark indices ended mostly unchanged on Wednesday, as gains in the financial sector helped offset losses in the pharma stocks due to concerns over tariff threats from Trump.

Top Gainers and Losers

BEL emerged as the top gainer, rising by 3.54% to ₹253.25, with a significant trading volume of 2,15,15,689 shares. Hindalco also performed well, gaining 2.70% to reach ₹627.95, supported by a volume of 61,01,640 shares.

On the other hand, the top losers included Dr. Reddy’s Laboratories, which saw a decline of 2.48%, closing at ₹1167.75, with a trading volume of 30,62,075 shares. TCS also faced a loss of 2.28%, closing at ₹3785, with a volume of 43,66,517 shares.

Broader Market Indices Performance

The Nifty 50 index closed at 22,932.90, registering a minor decline of 0.05%. Meanwhile, the Nifty IT index took a harder hit, falling by 1.30% to close at 40,924.25.

Similarly, the Nifty Healthcare Index also faced downward pressure, slipping by 0.78% to settle at 13,363.85. These declines reflect a challenging session for key sectors in the Indian stock market today.

Oil Prices

As of February 19, 2025, at 04:00 PM, Brent Crude was trading at $76.37, up by 0.70%.

Conclusion

In conclusion, February 19, 2025, saw Indian benchmark indices end with minor losses, reflecting a mixed market sentiment.

While financial stocks provided some support, concerns over pharma stocks, especially in light of tariff threats from former President Trump, led to a lackluster performance in the broader market.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.